What this means
Researchers removed a lipid enzyme from brain stem cells in mice. The mice showed better brain signaling and memory tests. This was done in mice, so it does not show the same effect in people.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- Mice
- Kind of research
- Research in animals or cells
The science
- Original title
- Suppressing neural stem cell PLA2G7 restores inhibitory circuit function and improves cognition in aging mice.
- Authors
- Wu F, Wu Y, Qin B et al.
- Journal
- Nature aging
- Published
- Oct 14, 2026
- Study type
- Lab or animal study · indexed as animal research
- PMID
- 42875584 ↗
Abstract
Age-related cognitive decline is associated with altered inhibitory signaling in hippocampal circuits, but the mechanisms underlying this dysfunction remain incompletely understood. Neural stem cells (NSCs) persist in the adult hippocampus and influence brain function beyond generating new neurons, although the molecular signals involved remain unclear. Here we show that phospholipase A2 group VII (PLA2G7), a secreted lipid-metabolizing enzyme expressed in NSCs, negatively regulates inhibitory circuit function in the dentate gyrus. Conditional deletion of Pla2g7 in NSCs enhanced inhibitory inputs onto dentate granule cells and improved hippocampal cognition. Lipidomic profiling revealed PLA2G7-dependent remodeling of phospholipid composition, linking NSC-derived lipid metabolism to inhibitory synaptic regulation. Supplementation with phosphatidylcholine rescued PLA2G7-associated inhibitory synapse deficits. In aged mice, PLA2G7 suppression restored inhibitory circuit function, partially normalized circuit imbalance and improved cognition. These findings identify a non-neurogenic mechanism through which NSCs modulate hippocampal circuits and suggest PLA2G7 as a target for promoting cognitive function during aging.
Wu F, Wu Y, Qin B et al. Suppressing neural stem cell PLA2G7 restores inhibitory circuit function and improves cognition in aging mice. Nature aging. 2026. doi:10.1038/s43587-026-01202-2. PMID: 42875584. https://pubmed.ncbi.nlm.nih.gov/42875584/
Related research
Mixing a senescence-clearing drug with trametinib slowed glioma regrowth in mice
Researchers found a drug combination that cleared aging-like tumour cells in mice and slowed regrowth. This does not show the combination would work the same way in children.
Neuronal receptor remodeling in the aging periosteum: From single-cell atlases to regenerative targets.
The periosteum is the most densely innervated compartment of the skeleton and harbors periosteal stem cells expressing a broad repertoire of neuronal receptors traditionally associated with the nervous system.
The Oxidative-Mitochondrial-Inflammatory Axis in Retinitis Pigmentosa: Extracellular mtDNA as Biomarker and Therapeutic Read-Out.
Retinitis pigmentosa (RP) is the most common inherited retinal dystrophy (prevalence ~1:4000) and a leading Mendelian cause of working-age blindness.
Stem cells and exosomes studied for organ aging in animals
This is a review of 34 animal studies on stem cells and exosomes. It suggests these treatments may help aging organs, but the review does not show they work in people.
Fruit fly study finds a gene that helps remove aging gut cells
Researchers found a protein-making gene that rises in aging fruit fly gut cells and helps them get shed. This shows one possible way aging gut cells are cleared, but it is only a fruit fly finding.
Cells from a rare aging syndrome aged faster in a dish
Scientists grew skin-like cells from a patient with a rare aging syndrome and watched them age early. This is a lab study, so it does not show what happens in people.
See all research on Stem cell therapy →